Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Targeting Insomnia to Enhance Hot Flush Treatment in Women Receiving Therapy for Breast Cancer or Breast Cancer Risk-Reduction.

Trial Profile

Targeting Insomnia to Enhance Hot Flush Treatment in Women Receiving Therapy for Breast Cancer or Breast Cancer Risk-Reduction.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2010

At a glance

  • Drugs Venlafaxine (Primary) ; Zolpidem (Primary) ; Serotonin uptake inhibitors
  • Indications Hot flashes; Sleep disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 04 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Dec 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top